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The parathyroid glands develop with the thymus from bilateral common primordia that develop from the 3rd pharyngeal pouch endoderm in
mouse embryos at about E11, each of which separates into one parathyroid gland and one thymus lobe by E13.5. Gcm2, a mouse ortholog of the
Drosophila Glial Cells Missing gene, is expressed in the parathyroid-specific domains in the 3rd pouches from E9.5. The null mutation of Gcm2
causes aparathyroidism in the fetal and adult mouse and has been proposed to be a master regulator for parathyroid development. In order to study
how Gcm2 functions in parathyroid development, we investigated the mechanism that causes the loss of parathyroids in Gcm2 null mutants.
Analysis of the 3rd pouch-derived primordium in Gcm2−/− mutants showed the parathyroid-specific domain was present before E12.5 but
underwent programmed cell death between E12 and 12.5. RNA and protein localization studies for parathyroid hormone (Pth) in wild-type
embryos showed that the presumptive parathyroid domain in the parathyroid/thymus primordia started to transcribe Pth mRNA and produce PTH
protein from E11.5 before the separation of parathyroid and thymus domains. However in Gcm2−/− mutants, the parathyroid-specific domain in
the common primordium did not express Pth and could not maintain the expression of two other parathyroid marker genes, CasR and CCL21,
although expression of these two genes was initiated. Marker gene analysis placed Gcm2 downstream of the known transcription and signaling
pathways for parathyroid/thymus organogenesis. These results suggest that Gcm2 is not required for pouch patterning or to establish the
parathyroid domain, but is required for differentiation and subsequent survival of parathyroid cells.
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Mammals are equipped with an efficient system to regulate
ionized calcium and phosphorus homeostasis in the extracel-
lular environment that is composed of parathyroid glands, bone,
kidney and intestine. In this system, the parathyroid glands are
the most important endocrine regulator to maintain the calcium
homeostasis in the circulation (Ramasamy, 2006). The primary
function of the parathyroids is to produce and release an 84-
amino acid hormone called parathyroid hormone (PTH), which
directly targets receptors on osteoblasts to regulate bone
resorption and on distal tubule epithelial cells in the kidney to
increase renal calcium reabsorption (Houillier et al., 2003). PTH
also indirectly stimulates intestinal calcium absorption by⁎ Corresponding author. Fax: +1 706 583 0691.
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2006). The requirement of PTH in the regulation of calcium
homeostasis was found not only postnatally, but also at fetal
stages (Kovacs et al., 2001a,b; Miao et al., 2002). PTH is also
essential for fetal bone formation (Miao et al., 2002). The
production and secretion of PTH in the parathyroid glands are
controlled by the membrane-bound calcium-sensing receptor
(CasR), which regulates PTH secretion by sensing the changes
of extracellular ionized calcium concentration (Chang and
Shoback, 2004; Chen and Goodman, 2004).
Serum calcium plays many physiological functions includ-
ing neuromuscular excitability, muscle contraction, blood
coagulation and bone mineralization (Ramasamy, 2006). Due
to the importance of PTH in the calcium homeostasis, PTH
deficiency (hypoparathyroidism) caused by the failure of or
disorders in parathyroid development causes disease in humans
(Thakker, 2001). Hypoparathyroidism can be caused by the
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physiological functions, including Pth (Ahn et al., 1986;
Goswami et al., 2004) and CasR (Suzuki et al., 2005; Thakker,
2004). It also can result from the mutation of genes that function
in parathyroid development, like Gata3(Van Esch et al., 2000),
Sox3 (Bowl et al., 2005) and Gcm2 (Ding et al., 2001; Thomee
et al., 2005). The study of parathyroid organogenesis can
therefore help us to understand the mechanisms of human
hypoparathyroidism.
In mouse, the parathyroids are bilateral organs that develop
with the thymus from two common parathyroid/thymus
primordia originating from the 3rd pharyngeal pouch endoderm.
Beginning at E8.0, the pharyngeal endoderm develops four
bilateral pouches that give rise to several organs, including the
thymus and parathyroids (Graham, 2003; Graham and Smith,
2001). The 3rd pharyngeal pouches are formed at E9.5–10 days
and are patterned into dorsal/anterior parathyroid and ventral/
posterior thymus domains (Gordon et al., 2001; Moore-Scott
and Manley, 2005; Patel et al., 2006). The 3rd pouch endoderm
proliferates to form bilateral parathyroid/thymus common
primordia at E11–11.5. Each primordium separates into one
parathyroid gland and one thymus lobe at E12.5–13.5, which
then migrate to their eventual adult locations by about E14.5
(Blackburn and Manley, 2004; Manley, 2000; Manley and
Blackburn, 2003). In the adult mouse, the parathyroids are
located near or embedded within the thyroid gland, and the
thymus is situated in the anterior chest cavity. Thus, the early
stages of parathyroid organogenesis are closely linked with
thymus organogenesis.
The molecular mechanisms that regulate pouch patterning
and early parathyroid/thymus organogenesis are beginning to be
identified. The Hoxa3, Pax1/9, Eya1 and Six1/4 transcriptional
regulators have been implicated as a pathway/network regulat-
ing early organogenesis of both organs, since mice that lack
these genes have normal initial pouch formation, but then fail to
form or have hypoplastic parathyroids and thymus. The Hoxa3
null mutation causes the most severe defects in parathyroid/
thymus organogenesis, as the Hoxa3−/− mutants fail to initiate
the formation of the parathyroid/thymus primordia (Chisaka and
Capecchi, 1991; Kameda et al., 2004; Manley and Capecchi,
1995, 1998; Su and Manley, 2002). A Pax1/9-Eya1-Six1/4
network has been identified to act downstream of Hoxa3 during
patterning and early organogenesis of both the thymus and
parathyroids (Dietrich and Gruss, 1995; Manley and Capecchi,
1995; Neubuser et al., 1995; Peters et al., 1998; Su et al., 2001;
Su and Manley, 2000; Wallin et al., 1996; Xu et al., 2002; Zou et
al., 2006).
The mechanism by which the parathyroid- and thymus-
specific domains in the 3rd pouch and subsequent primordia
are specified is beginning to be understood. Gcm2 and Foxn1
are organ-specific transcription factors that are localized to the
parathyroid- or thymus-specific domains of the common
primordia before their separation (Gordon et al., 2001).
Foxn1 expression begins at E11.25 in a domain that is
complementary to Gcm2 expression in the parathyroid/thymus
primordia (Gordon et al., 2001). The Foxn1 null mutation,
nude, causes failure of thymic epithelial cell differentiationbut does not affect the initiation of thymus organogenesis
(Blackburn et al., 1996; Nehls et al., 1996). The Gcm2 null
mutation has been reported to cause complete and specific
failure of parathyroid development (Gunther et al., 2000).
Gcm2 expression begins at E9.5 in the dorsal–anterior
pharyngeal endoderm of the 3rd pouch and is maintained in
the presumptive parathyroid domain at later stages (Gordon
et al., 2001). The early expression pattern and apparent
failure of parathyroid organogenesis suggest that Gcm2 may
specify the parathyroid domain in the 3rd pharyngeal pouch
prior to primordium formation and be required for initial
organogenesis.
Gcm2 is member of the Glial Cells Missing (Gcm)
transcription factor family, which have a conserved Gcm
DNA binding domain (Cohen et al., 2003). The first Gcm gene
was found in Drosophila, which was shown to function to as a
binary switch between neuronal and glial cells determination in
Drosophila central nervous system (Hosoya et al., 1995; Jones
et al., 1995). In mammals, there are two Gcm orthologs: Gcm1
and Gcm2 (Kim et al., 1998). However, neither gene is required
in the nervous system in mice. Gcm1 is expressed at the
placenta and is required for labyrinth formation (Schreiber et al.,
2000), while Gcm2 expression is restricted to the parathyroid
gland (Gordon et al., 2001; Gunther et al., 2000; Kim et al.,
1998). The role of Gcm as a binary switch specifying glial cell
fate in Drosophila nervous system development and the
complementary expression domains of Foxn1 and Gcm2 in
the common primordium suggest that parathyroid organogen-
esis may fail in Gcm2−/− mutants because the parathyroid
domain is transformed to a thymus fate. This possibility is
supported by previous studies in our lab of the Sonic hedgehog
(Shh) mutant phenotype. In the Shh null mutant, Gcm2 is never
expressed, and no parathyroid domain forms. In contrast, there
is an expanded thymus domain in the 3rd pouch, marked by
expanded Bmp4 and subsequently Foxn1-positive domains
(Moore-Scott and Manley, 2005; Patel et al., 2006). These
results are consistent with a model in which in the absence of
Shh, and therefore of Gcm2, the parathyroid domain may be
transformed to a thymus fate.
In the current study, we determined the role of Gcm2 in
parathyroid organogenesis by studying the mechanism of
aparathyroidism in Gcm2−/− mutants. In contrast to previous
reports, we showed that the parathyroid-specific domain was
present and morphologically normal until E12 in Gcm2−/−
embryos. However, parathyroid-specific markers were either
not expressed or not maintained at E11.5, and the parathyroid
domain underwent coordinated programmed cell death at E12
and was totally lost by E12.5. Consistent with these and
previous results, marker gene analysis showed normal expres-
sion of the Hoxa3-Pax1/9-Eya1 transcription factor and the
Shh-Bmp4 signaling networks in Gcm2−/− mutants, indicating
that these pathways act upstream of Gcm2. We further found
that Tbx1 expression, which is also restricted to the parathyroid-
specific domain in the 3rd pouch and/or the parathyroid/thymus
common primordia, was not affected by the Gcm2 null
mutation. This raises the possibility that Tbx1 may function to
specify the parathyroid-specific domain downstream of Shh and
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expression at E9.5, Gcm2 is not required for early patterning
of the dorso-anterior parathyroid domain or initiation of
parathyroid organogenesis. Also, Gcm2 does not act as a
binary cell fate switch between parathyroid and thymus fates
in the 3rd pouch, but is instead required for the differentiation




The generation of the Gcm2 null mutant and genotyping have been
described (Gunther et al., 2000). Gcm2 mutant mice used for experiments were
originated on 129/SvEv-C57BL/6J and had been backcrossed to C57BL/6J mice
for more than 4 generations.
Pax9lacZ (Peters et al., 1998), Bmp4lacZ (Lawson et al., 1999) and NogginlacZ
(McMahon et al., 1998) alleles were each crossed withGcm2+/– to obtain double
heterozygous F1 mice, which were then crossed with Gcm2+/– to produce Gcm2
homozygous mutants carrying the marker alleles for analysis.
Embryos were collected with the day of the vaginal plug designated as E0.5.
We also used somite number, eye pigment and the morphology of parathyroid/
thymus primordium to stage the embryos. All experiments were carried out with
the approval of the UGA institutional animal care committee.
TUNEL assay
The TUNEL assay was performed as described (Su et al., 2001). Staged
embryos were fixed in 4% paraformaldehyde for 2 h and processed for paraffin
embedding. Sections were cut at 8 μm. The TUNEL assay was performed on the
paraffin-embedded tissue sections following the manufacturer's guidelines
(Roche Diagnostics).
Immunohistochemistry
PTH immunohistochemistry was performed using an anti-PTH antibody as
described (Wurdak et al., 2005). Staged embryos were fixed in 4%
paraformaldehyde overnight and processed for paraffin embedding. Sections
were cut at 8–10 μm and stained with a goat anti-PTH antibody using the
Vectastain method (VectorLab).
Section and whole-mount in situ hybridization
Paraffin section in situ hybridization was performed as described (Moore-
Scott and Manley, 2005). Staged embryos were fixed in 4% paraformaldehyde
overnight and processed for paraffin embedding. 8–10 μm sections were
hybridized with digoxigenin-labeled RNA probes at 0.5 μg/ml. Alkaline
phosphatase-conjugated antidigoxigenin Fab fragments were used at 1:5000.
BM-purple (Roche) was used as a chromogen to localize hybridized probe.
Probes for Gcm2 and Foxn1 (Gordon et al., 2001), Tbx1 (Chapman et al., 1996),
CasR (Bowl et al., 2005), Shh (Echelard et al., 1993) and Ptc1 (Goodrich et al.,
1996) have been described. CCL21 probe was a gift from Yousuke Takahama.
Pth probe was cloned using the primers 5-CTGCAGTCCAGTTCATCAGC-3
and 5-AAGCTTGAAAAGGTAGCAGCA-3.
For the Foxn1 section in situ hybridization on the alternative sections
with the sections used for TUNEL experiment, the paraffin sections prepared
for TUNEL experiment were refix in 4% paraformaldehyde for 20 min after
rehydrate, then preformed section in situ hybridization like normal
procedure.
Whole-mount in situ hybridization was performed as described (Carpenter
et al., 1993; Manley and Capecchi, 1995). Probes for Hoxa3 (Manley and
Capecchi, 1995), Pax1(Manley and Capecchi, 1995) and Eya1(Xu et al., 1997)
have been described. Gcm2, Tbx1, CasR and CCL21 probes were the same as
the above used for section in situ hybridization.X-gal staining
Whole-mount X-gal staining was performed to the staged embryos as
described (Patel et al., 2006). After lacZ staining, embryos were embedded in
paraffin and 8 μm sections cut and counterstained with nuclear fast red.Results
Initial parathyroid domain formation is normal in Gcm2 null
mutants
Previous studies had concluded that the parathyroids were
absent in Gcm2−/− embryos as early as E11.5 (Gunther et al.,
2000). To investigate how parathyroid organogenesis fails in
Gcm2−/− mutants, we performed a detailed morphological and
cell fate analysis of the 3rd pouch-derived primordium in
control and Gcm2 mutant embryos from E10.5 to E13.5. Gcm2
expression is normally restricted to a small dorso-anterior
domain in the third pouch and in the subsequent shared organ
primordium, with Foxn1 expressed in the remainder of the
primordium after E11.5 (Gordon et al., 2001) (Figs. 1A–C). As
Gcm2 mRNA is not present in the mutant embryos, we used
Foxn1 gene expression as a marker for thymus cell fate to
assess the formation of the parathyroid domain in Gcm2
mutants. The Foxn1-expressing thymus domain was normal at
all time points assayed, and the presumptive parathyroid
domain was clearly identifiable as a Foxn1-negative domain at
the dorsal and anterior aspect of the common parathyroid/
thymus primordium at E11.25, E11.5 and E12 in both wild-
type and mutant embryos (Figs. 1C–F, and data not shown).
At E12.5–13, we saw presumptive parathyroids consisting of
Foxn1-negative cells separating from the thymus domain in
the wild-type embryos (Figs. 1G, I). However, at these stages
the parathyroid domain was absent in the Gcm2−/− embryos
(Figs. 1H, J). Thus, the parathyroid domain did form in
Gcm2−/− embryos and initially appeared morphologically
normal but was lost by E12.5. Furthermore, the parathyroid
domain does not appear to be transformed to a thymus-specific
fate, since in Gcm2−/− embryos the Foxn1-positive thymus
domain did not expand to the whole primordium at E11.25–12
(Figs. 1D, F).
Loss of the parathyroid domain in Gcm2−/− mutants by
programmed cell death
To determine whether the presumptive parathyroid domain
underwent programmed cell death in Gcm2−/− mutants, we
used the TUNEL assay at E11.5–12.5. At E11.5, there was no
difference between Gcm2 null mutant and WT control embryos
(Figs. 2A and B). As we have previously reported, at this stage
apoptosis is normally present at in the region of endoderm
where the primordium is separating from the pharyngeal pouch
(Gordon et al., 2004). This apoptosis is very transient, and at
E12 few or no TUNEL-positive cells were seen in the wild-type
primordium (Fig. 2E). In contrast, there was a concentration of
apoptotic cells in the presumptive parathyroid-specific domain
at E12 in the Gcm2 null mutants (Fig. 2F). We confirmed that
Fig. 1. Cell fate analysis of the 3rd pouch-derived parathyroid/thymus common primordia in wild-type and Gcm2−/− mutant embryos. Section in situ hybridization of
Gcm2 on sections of wild-type embryos at E11.5 (A) and E12.5 (B) embryos is shown for comparison. Foxn1 in situ hybridization was performed on the sections from
wild-type (C, E, G and I) andGcm2−/− (D, F, H and J) embryos at E11.5 (C, D), E12 (E, F), E12.5 (G, H) and E13 (I, J) stages. Sections were cut in the sagittal plane. In
all figures, anterior is up, and dorsal is to the right. Ages of embryos are indicated in the upper right corner of each panel. The thymus domains in panels A and B and
the parathyroid domains in panels C–J are outlined. pt, parathyroid; th, thymus.
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parathyroid domain by in situ hybridization for Foxn1 on
alternate sections (Figs. 2C, D). At E12.5, apoptosis could not
be detected in the Gcm2−/− mutants (data not shown), consistent
with the absence of the parathyroid domain at this time point
(Fig. 1H). These results indicated that loss of the presumptive
parathyroid domain was via coordinated apoptosis between E12
and E12.5.Parathyroid differentiation initiated but was subsequently
blocked in Gcm2−/− mutants
To determine the earliest time point when parathyroid
differentiation markers initiate and whether they were ever
expressed in the Gcm2−/− mutants prior to loss of the
parathyroid domain at E12.5, we assayed the expression of
calcium sensor receptor (CasR), the chemokine CCL21 and
Fig. 2. TUNEL analysis of cell death in the parathyroid/thymus primordia in wild-type and Gcm2−/− mutant embryos. TUNEL was performed on a complete sagittal
section series prepared from wild-type controls (A, E) and Gcm2−/− embryos (B, F) at E11.5 (A and B) and E12 (E and F) stages. Anterior is up, and dorsal is to the
right. In panels A–B, the common parathyroid/thymus primordium is outlined in white, and the 3rd pouch from which the primordium is undergoing separation by
apoptosis is outlined in yellow (PIII). At E12, in situ hybridization for Foxn1 to indicate the thymus domain (C, D) was performed on alternate sections with the
sections used for TUNEL (E, F) to confirm that the location of the apoptotic cells are in the parathyroid domain in Gcm2 null mutant. The dorso-anterior parathyroid
domain at E12 is indicated by a dashed line in panels C–F. The apoptotic cells in the parathyroid domain are indicated with a white arrow in panel F.
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This analysis was performed to determine whether parathyroid
specification and differentiation was initiated in Foxn1-negative
domain in the Gcm2 mutants at E10.5–11.5.
The two earliest differentiation markers for the parathyroid
domain other than Gcm2 are the calcium sensing receptor
(CaSR) and the chemokine CCL21. CasR is functionally
required for parathyroid cells to respond to modulating calcium
concentrations. Our previous study showed that CCL21 protein
is produced by the parathyroid-specific domain at E11.5 and is
absent from the parathyroid domain in Gcm2−/− mutants at
E11.5 (Liu et al., 2006). This result indicated that Gcm2
regulates parathyroid-specific expression of CCL21, and
providing functional evidence that the parathyroids play a role
in the attraction of hematopoietic-derived T-lymphoid progeni-
tor cells to the developing parathyroid/thymus primordium.
Both CCL21 and CaSR mRNA are expressed in the dorso-
anterior Gcm2-positive parathyroid domain of the 3rd pouch at
E10.5 in wild-type embryos (Figs. 3A, C, E) (Bowl et al., 2005).CasR is also expressed in a similar domain of the other three
pharyngeal pouches at E10.5 (Fig. 3E), but by E11 CasR
expression was specifically maintained in the dorsal parathyroid
domain of the 3rd pouch but down-regulated in the other three
pouches (Fig. 3G). In Gcm2−/− mutants, both CCL21 and CasR
expressions in the pharyngeal region were initiated normally,
although CCL21 was reduced compared to controls (Figs. 3D,
F). At E11, CaSR was not maintained in pouch 3 (Fig. 3H).
Thus, expression of both of these early parathyroid markers was
initiated in the Gcm2 mutants, indicating that the initial
patterning of the parathyroid domain in the 3rd pouch is normal
in the Gcm2−/− mutants.
At E11.5 in control embryos, both CasR and CCL21 were
present specifically in the parathyroid domain of the common
primordium (Figs. 4A, B, D). In contrast, both of these markers
were absent from the presumptive parathyroid domain in the
common primordium in E11.5 Gcm2−/− mutants (Figs. 4C, E).
These results show that while the initial expression of
parathyroid-specific markers does not absolutely require
Fig. 3. The expression of CasR and CCL21 in wild-type and Gcm2−/− mutant embryos. Whole-mount in situ hybridization for Gcm2 at E10.5 (A) and E11 (B) is
shown for comparison. CCL21 (C, D) and CasR (E–H) expressions are shown in wild-type (C, E, G) andGcm2−/− (D, F, H) embryos at E10.5 (C–F). CasR expression
is also shown at E11 (G, H). In all panels, dorsal is to the right, anterior is up. CasR expression was initiated at the dorsal sides of all four pouches (p1–p4) in the wild-
type E10.5 embryo (E), and this expression was not affected by Gcm2 null mutation (F). The initiation of CCL21 expression at the dorsal side of 3rd pouch (C)
partially required Gcm2 function (D). CasR expression was maintained only in the parathyroid domain at E11 in the wild-type (G), and this expression required Gcm2
function (H). In A–D, arrows indicate dorsal/anterior parathyroid domains. a1, first arch; a2, second arch.
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and for maintenance of both CCL21 and CasR expressions in
the parathyroid domain of the shared primordium.
Perhaps the most characteristic parathyroid marker is
parathyroid hormone. The major function for the mature
parathyroid glands is to produce and secrete PTH in the
circulation to regulate extracellular calcium concentration. Pth
mRNA has been detected in the presumptive parathyroid
domain as early as E11.5 (Gunther et al., 2000). To determine
whether this represented the earliest time point of Pthexpression, we checked Pth mRNA expression and protein
localization in the wild-type embryos beginning at E9.5, when
Gcm2 is first expressed in the 3rd pouch. At E9.5 and E10.5,
Pth mRNA was not detected in the 3rd pouch (Fig. 5A and
data not shown). The initial expression of Pth mRNAwas seen
at E11.5 in the parathyroid-specific domain (the anterior and
dorsal part) of the parathyroid/thymus primordium (Fig. 5B),
consistent with previous data (Gunther et al., 2000). PthmRNA
was then maintained in the parathyroid at all subsequent stages
examined (Figs. 5C–F). The timing of initial Pth expression
Fig. 4. Maintenance of CCL21 and CasR expression in the parathyroid domain at E11.5 requiresGcm2. Sections were cut at sagittal plane. In all figures, anterior is up,
and dorsal is to the right. The common parathyroid/thymus primordium is outlined and the parathyroid domain is indicated with an arrow in panels A, B, D. In situ
hybridization for Gcm2 at E11.5 (A) is shown for comparison. CCL21 (B) and CasR (D) are restricted to the parathyroid domain at E11.5 in wild-type embryos.
Neither is expressed in Gcm2 mutants (C, E).
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cells, compared to CCL21 and CasR. Immunohistochemistry
using a PTH antibody also showed that PTH protein was
produced in the parathyroid-specific domain as early as E11.5,
as soon as Pth mRNAwas detected, and was maintained in the
parathyroid at all subsequent stages examined (Figs. 5G–I).
These Pth mRNA and protein studies suggest that the
parathyroid precursor cells in the parathyroid-specific domain
can produce PTH at E11.5, prior to separation from the thymus
in wild-type embryos. However, Pth mRNA and protein were
never present in the parathyroid domain in Gcm2−/− mutant
embryos (Figs. 5J–N), even though the parathyroid domain is
morphologically normal before E12.5 in Gcm2−/− mutant
embryos (Figs. 1D, F). This result confirms that Pth expression
requires Gcm2 as in the previous report (Gunther et al., 2000).
Taken together, these marker studies present a time course of
parathyroid differentiation, initiating with Gcm2 at E9.5,
followed by CCL21 and CasR at E10.5 and Pth at E11.5. The
earliest markers of the parathyroid domain, CaSR and CCL21,
are both initiated at the right time and place in Gcm2 mutants
and are entirely or partially independent of Gcm2 at this stage.
However, subsequent differentiation, as indicated by initiating
Pth expression and maintenance of the early markers, failed
in the Gcm2 mutants.
Tbx1 expression in the dorsal pouch is normal in Gcm2
mutants
Our previous studies and others have shown that the
transcription factor Tbx1 is also expressed in the dorsal and
anterior 3rd pouch endoderm in wild-type embryos at E10.5,strikingly similar to the Gcm2 expression domain (Manley et
al., 2004; Vitelli et al., 2002; Zhang et al., 2005) (Figs. 6A
and C). Tbx1 has also been identified as a downstream target
of Shh signaling in the pharyngeal endoderm (Garg et al.,
2001; Yamagishi et al., 2003), as has Gcm2 (Moore-Scott and
Manley, 2005). Gcm2 expression at E10.5 and parathyroid
organogenesis are also absent in Tbx1−/− mutants, although in
this case the loss is secondary to the absence of the 3rd and
4th pouches (Ivins et al., 2005; Jerome and Papaioannou,
2001; Vitelli et al., 2002). Consistent with this early similarity
between Tbx1 and Gcm2 expression, at E11.5 Tbx1 expres-
sion was restricted to the parathyroid-specific domain (Fig.
6E). There was no change in Tbx1 expression in Gcm2−/−
mutant embryos at E10.5 or E11. 5 (Figs. 6B, D, F). The
restricted expression pattern of Tbx1 in the 3rd pouch
endoderm and in the parathyroid-specific domain of the
common primordium in the Gcm2 mutants places Tbx1
upstream of Gcm2 in the parathyroid domain.
Gcm2 is downstream of known transcription factor and
signaling networks in parathyroid/thymus organogenesis
A number of transcription factor and signaling pathways
have been identified as playing a role in the patterning of the
third pouch into parathyroid and thymus domains and/or in the
initiation of primordia formation. Mutants for Hoxa3, Pax1,
Pax9, Eya1 and Shh all have absent or reduced Gcm2
expression at E10.5–11.5 (Moore-Scott and Manley, 2005; Su
et al., 2001; Xu et al., 2002). These transcription factor and
signaling pathways should function upstream to Gcm2, based
on their expression patterns and mutant phenotypes.
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Fig. 6. Expression of Tbx1 in wild-type and Gcm2−/− mutant embryos. Whole-mount (A, B) or paraffin section (C–F) in situ hybridization for Tbx1 at E10.5 (A–D)
and E11.5 (E, F). In the wild-type, Tbx1 expression was present at the dorsal side of 3rd pouch at E10.5 (A, C) and at the parathyroid-specific domain in the
parathyroid/thymus primordium at E11.5 (E). This expression is not affected by Gcm2 null mutation (B, D, F). In A and B, anterior is up, and dorsal is to the left.
Sections were cut in the sagittal plane. In C–F, anterior is up, and dorsal is to the right. Arrows in panels E and F indicate the parathyroid domain. p3, third pouch; a1,
first arch; a2, second arch.
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Eya1 pathway, we studied these genes' expression in Gcm2−/−
mutants using whole-mount in situ hybridization or LacZ
reporter transgenic mice. Hoxa3 (Figs. 7A and B), Pax1 and
Pax9 (Figs. 7C–F) and Eya1 expression (Figs. 7G and H)
were all the same in both wild-type and Gcm2−/− mutant
embryos. Combined with previous data, these results show that
Gcm2 expression is downstream of this transcriptional network.
Our previous data have implicated the Shh and Bmp4
signaling pathways in the patterning of the organ-specific
domains in the 3rd pouch, with Shh required for parathyroid
domain formation and Gcm2 expression, and opposing Bmp4
in the presumptive thymus domain (Moore-Scott and Manley,Fig. 5. The expression of Pth in wild-type and Gcm2−/− mutant embryos. Section in sit
embryos at E10.5 (A), E11.5 (B), E12 (C), E12.5 (D), E13.5 (E) and E18.5 (F). Immuno
embryos at E11.5 (G), E12.5 (H) and E18.5 (I). The initiation of Pth mRNA and prote
mRNA and protein expressions were also not present in late stages at E12 (K and N) a
dorsal is to the right. Arrows in panels B–I, indicate the parathyroid domains or parathy
C, G, H and J–N. p3, third pouch; a1, first arch; a2, second arch; h, heart; th, thymus2005; Patel et al., 2006). The Bmp antagonist Noggin is also
expressed in the dorsal anterior 3rd pouch overlapping with
Gcm2 at E10.5–11.5 (Patel et al., 2006). In situ hybridization
for Shh and Ptc in wild-type and Gcm2−/− mutant embryos did
not show any difference (Figs. 8A–D), consistent with this
signaling pathway functioning upstream Gcm2. We used
Bmp4lacZ and NogginlacZ transgenic mouse strains to perform
a detailed study of Bmp4 and noggin expression from E10.5 to
11.5 in the wild-type and Gcm2−/− mutant embryos. Both
Bmp4 and noggin expressions were unchanged in wild-type
and Gcm2−/− mutant embryos at all stages tested (Figs. 9A–L),
suggesting that this pathway is also not affected by
Gcm2 mutation, and confirming co-localization of Bmp4 withu hybridization of Pth was performed on the sections prepared from the wild-type
histochemistry of PTHwas performed on the sections prepared from the wild-type
in expression was not present in the Gcm2−/− mutants at E11.5 (J and M), and Pth
nd E12.5 (L). Sections were cut at sagittal plane. In all figures, anterior is up, and
roid glands. The common parathyroid/thymus primordium is outlined in panels B,
; tr, thyroid; pt, parathyroid.
Fig. 7. Expression of the Hoxa3-Pax1/9-Eya1 pathway in wild-type and Gcm2−/− mutant embryos. Whole-mount in situ hybridization (A–D, G and H) or LacZ
staining (E and F) was performed on wild-type (A, C, E and G) and Gcm2−/− (B, D, F and H) embryos at E10.5 for Hoxa3 (A and B), Pax1 (C and D), Pax9 (E and F)
and Eya1 (G and H). The expression of these genes in the 3rd pouch was normal in Gcm2 mutants. The 3rd pouch is indicated in each panel (p3).
342 Z. Liu et al. / Developmental Biology 305 (2007) 333–346presumptive thymus cells and normal patterning of the pouch
and primordium in the Gcm2−/− mutants.
Discussion
Our data suggest that Gcm2 is required for the differentiation
of parathyroid precursor cells in the parathyroid-specific domain
but is not required for initial patterning or initial expression of
differentiation markers of the parathyroid domain in the 3rd
pharyngeal pouches and common parathyroid/thymus primordia.
Our data also show that Gcm2 acts downstream of the known
transcription and signaling pathways that function in parathyroid/thymus organogenesis. In this gene network, Gcm2 acts as a
parathyroid-specific regulator gene for parathyroid differentia-
tion, such that in the absence of Gcm2 the parathyroid precursor
cells form and express initial differentiation markers, but cannot
complete differentiation, and subsequently undergo apoptosis.
Based on its expression pattern, the initial description of the
Gcm2 mutant phenotype in mouse, the Shh mutant phenotype
and the role of the Drosophila Gcm gene in cell fate
specification, Gcm2 has been proposed by us and others to act
as the master regulator gene that establishes the initial
specification of the parathyroid domain (Balling and Erben,
2000; Berg, 2002; Manley and Blackburn, 2004). This role for
Fig. 8. Expression of Shh and Ptc1 in the 3rd pouch of wild-type and Gcm2−/− mutant embryos. Section in situ hybridization for Shh (A and B) and Patched1 (C and
D) was performed on transverse paraffin sections from wild-type (A and C) and Gcm2−/− (B and D) embryos at E10.5. The expression of these genes in the 3rd pouch
was normal in Gcm2 mutants. Dorsal is up. p3, third pouch.
343Z. Liu et al. / Developmental Biology 305 (2007) 333–346Gcm2 predicted that aparathyroidism in the Gcm2 mutants
would be due to failure to specify the parathyroid domain in the
third pouch. This failure might then result in either early
apoptosis of the cells that would normally form the parathyroid
domain in the third pouch, or transformation of the parathyroid
domain to a thymus fate.
Our results did not support either of these predicted roles for
Gcm2. The cell fate analysis of the 3rd pouch-derived
parathyroid/thymus primordium showed that the parathyroid
domain formed and was morphologically normal before E12.5 in
Gcm2−/− mutants. Gcm2 also did not act as a binary switch
between parathyroid and thymus fates since the presumptive
parathyroid domain did not express the thymus-specific marker
Foxn1 in Gcm2−/− mutants and did express the early parathyroid
differentiation markers CaSR and CCL21. The Foxn1 expressing
domains were also a similar size in Gcm2−/− mutants and wild-
type controls, and Bmp4 expression in the presumptive thymus
domain was also normal in Gcm2−/− embryos. These results
further showed that Gcm2 does not normally act to suppress
thymus fate or thymus-specific gene expression in the para-
thyroid domain in the third pouch.
Our results showGcm2 is required for the differentiation of the
parathyroid domain after it is formed. Among three different
parathyroid cell marker genes we test in Gcm2−/− mutants, we
found three different regulation models. Gcm2 is required for
initial Pth expression at E11.5. On the other hand, the initial
expression of CasR and CCL21 genes is at least somewhat
independent of Gcm2 but do require Gcm2 to maintain their
expression. For CasR, this may not be surprising, as it is initially
expressed in all four pouches at E10.5—in this case,Gcm2 seems
to take the role of maintaining expression only in the parathyroiddomain. However, CCL21 expression is initially restricted to the
3rd pouch but only partially depends on Gcm2 for full initial
expression levels. The expression analysis of these three
parathyroid differentiation markers reveals a surprising complex-
ity in the regulation of parathyroid differentiation and indicates
that at least one other transcription factor is required to establish
correct initial expression of these factors. The maintenance of all
of these genes at later stages may also require Gcm2 since Gcm2
expression is maintained in adult parathyroid cells, although that
remains to be experimentally determined.
Gcm2 not only regulates the differentiation procedure of
parathyroid precursor cells, it is also required for their survival.
This phenotype may reflect a direct role for Gcm2 in promoting
cell survival. Our previous analysis of Hoxa3 +/−Pax1−/−
compound mutants showed that loss of Gcm2 expression after
E11.5 resulted in progressive loss of parathyroids (Su et al.,
2001). Interestingly, there was a delay of up to two days before
this phenotype was evident, similar to the time delay between
initial expression of Gcm2 at E9.5 and cell death at E12 in the
Gcm2 mutants. Alternatively, in the absence of normal
differentiation, parathyroid cells either fail to acquire respon-
siveness to survival signals in the environment or activate a
default apoptotic fate.
The restricted expression of several genes in the presumptive
parathyroid domain even in the absence of Gcm2 strongly
suggests that this domain is specified and initiates parathyroid
differentiation in these mutants. If Gcm2 does not specify the
parathyroid domain, what does? From its expression pattern and
its position upstream of Gcm2, Tbx1 is a likely candidate to
specify the parathyroid domain in the 3rd pouch. At E10.5,
Tbx1 expression is restricted to the dorsal and anterior part in
Fig. 9. Expression of Bmp4 and Noggin in the 3rd pouch of wild-type and Gcm2−/−mutant embryos. Whole-mount LacZ staining for Bmp4LacZ (A–F) and NogginLacZ
(G–L) was performed on wild-type (A, C, E, G, I and K) and Gcm2−/− (B, D, F, H, J and L) at E10.5 (A, B, G and H), E11 (C, D, I and J) and E11.5 (E, F, K and L). In
panels A–F, the black arrows indicate Bmp4 expression restricted to the ventral/posterior thymus domain in the 3rd pouch (p3) and common primordium. In panels E
and F, the Bmp4-negative dorsal domain is indicated with a white arrow. In panels G–L, arrows indicate dorsally restricted noggin domain. Arrowheads in panels G–L
indicate the ventral/posterior thymus domain.
344 Z. Liu et al. / Developmental Biology 305 (2007) 333–346the 3rd pouch endoderm that will become the parathyroid
domain (Manley et al., 2004; Vitelli et al., 2002; Zhang et al.,
2005) and remains restricted to the parathyroid domain in the
parathyroid/thymus primordia (Fig. 6E). This expression
pattern is consistent with Tbx1 functioning in early parathyroid
organogenesis. The Shh pathway is also required to establish the
parathyroid domain, as Gcm2 expression is lost and the thymus
domain extended into the pharynx in Shhmutants (Moore-Scottand Manley, 2005). Tbx1 is also thought to be a downstream
target of the Shh signaling pathway (Garg et al., 2001;
Yamagishi et al., 2003). Taken together, these data support a
model in which specification of the parathyroid domain is
regulated through a Shh-Tbx1-Gcm2 pathway.
In addition to the Shh pathway, a Hoxa3-Pax1/9-Eya1
pathway is also required for 3rd pouch patterning and initiation
of parathyroid/thymus primordium formation and may directly
345Z. Liu et al. / Developmental Biology 305 (2007) 333–346regulate Gcm2 expression. Gcm2 expression is absent or down-
regulated in Hoxa3−/− and Eya1−/− embryos at E10.5 (our
unpublished data) (Xu et al., 2002). Consistent with these data,
the expression of the Hoxa3-Pax1/9-Eya1 pathway in Gcm2−/−
embryos is normal at E10.5. How the Shh-Tbx1 and Hoxa3-
Pax1/9-Eya1 pathways converge to regulate Gcm2 and para-
thyroid cell fate is a key remaining question in understanding
parathyroid organogenesis.
The current results indicate that in spite of their different
timing for initial expression, both Gcm2 and Foxn1 play
analogous roles in the development of the parathyroid and
thymus domains in the common primordium—both genes are
not required for initial specification of the organ domains or
initial primordium formation but are required for subsequent
tissue-specific differentiation events. However, while Foxn1
initial expression is at E11.25, similar to the appearance of the
first identifiable phenotype, Gcm2 expression in the 3rd pouch
endoderm is initiated from E9.5, well before the parathyroid/
thymus primordium is formed. The decreased initial expression
of CCL21 does indicate some role for Gcm2 at least at E10.5,
even though it is not required for domain specification. The
earlier expression could also be due to differences in the timing
of expression of upstream regulation of the two genes. The
location of parathyroids within the endoderm of the pharyngeal
pouches is evolutionarily conserved and, in teleost fishes, is
required for gill bud formation, which precedes thymus
organogenesis in these animals (Graham et al., 2005; Okabe
and Graham, 2004; Schorpp et al., 2002; Willett et al., 1997).
The molecular pathways that specify the parathyroid domain
may turn on earlier than those of the thymus due to this
evolutionary legacy. A consequence of this earlier expression
may also be to carve out the parathyroid domain within the third
pouch and protect it from a thymus fate.
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